ALCLOMETASONE DIPROPIONATE

ALCLOMETASONE DIPROPIONATE was reported 314 times

ALCLOMETASONE DIPROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REACTION TO PREVIOUS EXPOSURE TO ANY VACCINE 1 0.0769
1 DIVERTICULAR HERNIA 1 0.0667
2 EXANTHEMA SUBITUM 1 0.0294
3 VASCULAR GRAFT INFECTION 1 0.0227
4 BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL 1 0.0213
5 VERNAL KERATOCONJUNCTIVITIS 1 0.0200
6 UTERINE TENDERNESS 1 0.0116
7 EYELID EROSION 1 0.0115
8 SOMATIC DYSFUNCTION 1 0.0111
9 ADMINISTRATION SITE INFLAMMATION 1 0.0111
10 SKIN CANCER METASTATIC 1 0.0101
11 LUNG ADENOCARCINOMA RECURRENT 1 0.0097
12 ADJUSTED CALCIUM DECREASED 1 0.0094
13 CATHETER SITE SCAB 1 0.0093
14 HAIR FOLLICLE TUMOUR BENIGN 1 0.0090
15 ASTEATOSIS 1 0.0085
16 PARASPINAL ABSCESS 1 0.0065
17 POSTICTAL PSYCHOSIS 1 0.0064
18 GASTROENTERITIS ADENOVIRUS 1 0.0064
19 ADMINISTRATION SITE REACTION 2 0.0052
20 PLEURAL ADHESION 1 0.0050
21 MERALGIA PARAESTHETICA 1 0.0047
22 ECZEMA HERPETICUM 2 0.0043
23 VITAMIN B6 DEFICIENCY 1 0.0041
24 COLONIC OBSTRUCTION 1 0.0038
25 HEPATIC CANCER RECURRENT 1 0.0035
26 THERAPEUTIC PRODUCT CROSS-REACTIVITY 3 0.0034
27 BREAST CELLULITIS 1 0.0032
28 CELLULITIS STAPHYLOCOCCAL 2 0.0031
29 ADENOIDAL HYPERTROPHY 1 0.0026
30 MESENTERIC ARTERY THROMBOSIS 1 0.0026
31 ADENOIDECTOMY 1 0.0026
32 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
33 MOUTH BREATHING 1 0.0023
34 SYNOVIAL DISORDER 1 0.0022
35 APPLICATION SITE ACNE 1 0.0020
36 ROOT CANAL INFECTION 1 0.0020
37 PRODUCT CLOSURE ISSUE 1 0.0018
38 NAIL BED BLEEDING 1 0.0018
39 OPHTHALMIC HERPES SIMPLEX 1 0.0017
40 PNEUMONIA INFLUENZAL 2 0.0017
41 AURICULAR SWELLING 1 0.0017
42 STOMA SITE HYPERGRANULATION 1 0.0016
43 PERIORAL DERMATITIS 1 0.0016
44 POSTOPERATIVE ADHESION 1 0.0015
45 CATARACT NUCLEAR 1 0.0015
46 DERMATITIS DIAPER 1 0.0014
47 INFANTILE SPASMS 1 0.0014
48 CONJUNCTIVITIS ALLERGIC 2 0.0013
49 SENSITISATION 1 0.0013
50 SUPERINFECTION BACTERIAL 1 0.0013
51 MAMMOPLASTY 1 0.0013
52 ENDOMETRIAL HYPERPLASIA 1 0.0012
53 SEIZURE CLUSTER 1 0.0012
54 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 1 0.0012
55 MIGRAINE WITH AURA 3 0.0011
56 ANEURYSM RUPTURED 1 0.0011
57 SKIN TEST POSITIVE 1 0.0011
58 INTUSSUSCEPTION 1 0.0010
59 BONE SWELLING 1 0.0010
60 EYELID RASH 1 0.0010
61 PRINZMETAL ANGINA 1 0.0010
62 REBOUND ATOPIC DERMATITIS 2 0.0010
63 TRIGGER FINGER 4 0.0010
64 RADIATION PNEUMONITIS 2 0.0009
65 PNEUMONIA STREPTOCOCCAL 1 0.0009
66 TINEA INFECTION 1 0.0009
67 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
68 OTITIS EXTERNA 1 0.0008
69 ABORTION MISSED 1 0.0008
70 STOMA SITE INFECTION 1 0.0008
71 BLEPHARITIS 3 0.0007
72 BEZOAR 1 0.0007
73 APPLICATION SITE INFLAMMATION 1 0.0007
74 SUDDEN ONSET OF SLEEP 1 0.0007
75 CATAPLEXY 1 0.0007
76 NAIL INFECTION 1 0.0007
77 PARONYCHIA 3 0.0007
78 STOMA SITE PAIN 1 0.0007
79 GENERALISED ANXIETY DISORDER 1 0.0007
80 RHINITIS ALLERGIC 3 0.0007
81 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
82 EYELIDS PRURITUS 2 0.0006
83 BACTERIAL VAGINOSIS 1 0.0006
84 INFUSION SITE HAEMORRHAGE 2 0.0006
85 SEBORRHOEIC DERMATITIS 1 0.0006
86 SPINAL DEFORMITY 1 0.0006
87 TYMPANIC MEMBRANE PERFORATION 1 0.0006
88 INJECTION SITE OEDEMA 1 0.0006
89 ACUTE SINUSITIS 1 0.0006
90 SPONDYLOLISTHESIS 1 0.0006
91 INFUSION SITE DISCHARGE 1 0.0006
92 LYMPH NODE PAIN 1 0.0005
93 DYSENTERY 1 0.0005
94 THROAT CLEARING 2 0.0005
95 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
96 EAR HAEMORRHAGE 1 0.0005
97 AORTIC DISSECTION 2 0.0005
98 CATHETER SITE ERYTHEMA 1 0.0005
99 HERPES SIMPLEX 3 0.0005
100 INFECTIOUS MONONUCLEOSIS 1 0.0004
101 REACTION TO EXCIPIENT 1 0.0004
102 SLOW SPEECH 1 0.0004
103 RETINAL TEAR 1 0.0004
104 STAPHYLOCOCCAL SEPSIS 2 0.0004
105 ORGANISING PNEUMONIA 2 0.0004
106 URINARY TRACT INFECTION BACTERIAL 1 0.0004
107 DERMATOMYOSITIS 1 0.0004
108 ACTINIC KERATOSIS 1 0.0004
109 DERMATITIS 8 0.0004
110 EXFOLIATIVE RASH 1 0.0004
111 LUNG OPACITY 1 0.0004
112 SHOULDER ARTHROPLASTY 1 0.0004
113 SKIN DISCOMFORT 1 0.0004
114 ERYTHEMA OF EYELID 2 0.0004
115 PLEURITIC PAIN 1 0.0004
116 CEREBRAL THROMBOSIS 1 0.0004
117 GASTROINTESTINAL NECROSIS 1 0.0003
118 CREPITATIONS 1 0.0003
119 DERMATITIS ACNEIFORM 2 0.0003
120 DERMATITIS ALLERGIC 4 0.0003
121 EXPOSURE TO TOXIC AGENT 1 0.0003
122 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
123 APPLICATION SITE DRYNESS 1 0.0003
124 B-CELL LYMPHOMA 1 0.0003
125 BRONCHOPNEUMONIA 1 0.0003
126 NEPHROTIC SYNDROME 2 0.0003
127 REGURGITATION 1 0.0003
128 HAIR GROWTH ABNORMAL 2 0.0003
129 CONJUNCTIVAL HYPERAEMIA 1 0.0003
130 SKIN WEEPING 1 0.0003
131 APPENDICECTOMY 1 0.0003
132 PHARYNGITIS STREPTOCOCCAL 3 0.0003
133 NEURODERMATITIS 1 0.0003
134 SUNBURN 2 0.0003
135 CATHETER SITE INFECTION 1 0.0003
136 DERMATITIS CONTACT 3 0.0003
137 SKIN FISSURES 5 0.0003
138 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
139 SELF-MEDICATION 1 0.0002
140 SUICIDAL BEHAVIOUR 1 0.0002
141 ONYCHOMADESIS 1 0.0002
142 INTESTINAL STENOSIS 1 0.0002
143 SHOULDER OPERATION 1 0.0002
144 PRODUCT DISPENSING ISSUE 1 0.0002
145 INFUSION SITE PAIN 3 0.0002
146 SKIN HYPERPIGMENTATION 2 0.0002
147 BLOOD MAGNESIUM DECREASED 2 0.0002
148 OCULAR ICTERUS 1 0.0002
149 PULMONARY FUNCTION TEST DECREASED 1 0.0002
150 DERMATITIS ATOPIC 12 0.0002
151 SYNOVIAL CYST 1 0.0002
152 CONJUNCTIVITIS 4 0.0002
153 ARTHRITIS INFECTIVE 1 0.0002
154 SKIN TIGHTNESS 1 0.0002
155 SEASONAL ALLERGY 3 0.0002
156 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
157 EYE INFLAMMATION 2 0.0002
158 APPLICATION SITE BURN 1 0.0002
159 APPLICATION SITE SWELLING 1 0.0002
160 ERYSIPELAS 1 0.0002
161 KLEBSIELLA INFECTION 1 0.0002
162 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
163 APPLICATION SITE ERYTHEMA 5 0.0002
164 CATATONIA 1 0.0002
165 SKIN LACERATION 2 0.0002
166 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
167 STREPTOCOCCAL INFECTION 1 0.0002
168 SNEEZING 4 0.0002
169 CORONARY ARTERY BYPASS 1 0.0002
170 ECZEMA 9 0.0002
171 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
172 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
173 SYMPTOM RECURRENCE 1 0.0002
174 RESTLESSNESS 6 0.0002
175 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
176 LARYNGEAL OEDEMA 1 0.0002
177 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
178 SWELLING OF EYELID 1 0.0002
179 INFUSION SITE SWELLING 1 0.0002
180 GLAUCOMA 3 0.0002
181 SINUS DISORDER 3 0.0002
182 EAR INFECTION 4 0.0002
183 HAIR TEXTURE ABNORMAL 2 0.0001
184 ULCER HAEMORRHAGE 1 0.0001
185 OCULAR HYPERAEMIA 7 0.0001
186 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
187 ABNORMAL LOSS OF WEIGHT 1 0.0001
188 LARGE INTESTINE PERFORATION 1 0.0001
189 HYPOMAGNESAEMIA 2 0.0001
190 ANGINA PECTORIS 4 0.0001
191 TONGUE DISORDER 1 0.0001
192 GASTROENTERITIS 2 0.0001
193 HYDRONEPHROSIS 1 0.0001
194 PEMPHIGOID 1 0.0001
195 STOMATITIS 8 0.0001
196 AFFECTIVE DISORDER 1 0.0001
197 BLOOD ALBUMIN DECREASED 1 0.0001
198 SENSORY LOSS 1 0.0001
199 RHINITIS 1 0.0001
200 SHOCK HAEMORRHAGIC 1 0.0001
201 ASPHYXIA 1 0.0001
202 HICCUPS 1 0.0001
203 HAIR DISORDER 1 0.0001
204 EMBOLISM 1 0.0001
205 DRY EYE 6 0.0001
206 EOSINOPHIL COUNT INCREASED 1 0.0001
207 EYE PRURITUS 4 0.0001
208 SKIN EXFOLIATION 10 0.0001
209 PRODUCT CONTAINER ISSUE 1 0.0001
210 CARDIAC OPERATION 1 0.0001
211 PSYCHOLOGICAL TRAUMA 1 0.0001
212 SKIN SWELLING 1 0.0001
213 FACIAL PAIN 1 0.0001
214 HAEMOLYTIC ANAEMIA 1 0.0001
215 RETINAL DETACHMENT 1 0.0001
216 IRON DEFICIENCY ANAEMIA 1 0.0001
217 EYE SWELLING 4 0.0001
218 ERYTHEMA MULTIFORME 1 0.0001
219 SQUAMOUS CELL CARCINOMA 1 0.0001
220 FEBRILE NEUTROPENIA 7 0.0001
221 EYE IRRITATION 6 0.0001
222 PHARYNGEAL SWELLING 1 0.0001
223 INABILITY TO AFFORD MEDICATION 1 0.0001
224 BRAIN INJURY 1 0.0001
225 LACRIMATION INCREASED 3 0.0001
226 FULL BLOOD COUNT DECREASED 2 0.0001
227 CELLULITIS 5 0.0001
228 DRY THROAT 1 0.0001
229 EYE DISCHARGE 1 0.0001
230 TENDERNESS 1 0.0001
231 TRANSFUSION 1 0.0001
232 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
233 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
234 PULMONARY THROMBOSIS 1 0.0001
235 EXPIRED PRODUCT ADMINISTERED 3 0.0001
236 VENTRICULAR FIBRILLATION 1 0.0001
237 FUNGAL INFECTION 3 0.0001
238 DRY SKIN 12 0.0001
239 SKIN INFECTION 1 0.0001
240 OCULAR DISCOMFORT 1 0.0001
241 FISTULA 1 0.0001
242 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
243 EYE PAIN 5 0.0001
244 EYE INFECTION 1 0.0001
245 SCAB 1 0.0001
246 NEOPLASM 1 0.0001
247 NIGHTMARE 3 0.0001
248 MADAROSIS 1 0.0001
249 SPLENOMEGALY 1 0.0001
250 HYPOXIA 3 0.0001
251 PRODUCT PRESCRIBING ERROR 2 0.0001
252 HEPATITIS C 1 0.0001
253 INTERSTITIAL LUNG DISEASE 4 0.0001
254 ADRENAL INSUFFICIENCY 1 0.0001
255 SMALL INTESTINAL OBSTRUCTION 1 0.0001
256 INJECTION SITE EXTRAVASATION 1 0.0001
257 PHARYNGITIS 1 0.0001
258 HAIR COLOUR CHANGES 1 0.0001
259 ANOREXIA 1 0.0001
260 BREAST CANCER FEMALE 2 0.0001
261 PAIN OF SKIN 2 0.0001
262 PSORIATIC ARTHROPATHY 3 0.0001
263 NEUTROPHIL COUNT DECREASED 3 0.0001
264 PRURITUS 28 0.0001
265 APPLICATION SITE RASH 1 0.0001
266 PROCEDURAL PAIN 2 0.0001
267 ORAL DISCOMFORT 1 0.0001
268 CARPAL TUNNEL SYNDROME 1 0.0001
269 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
270 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
271 INTENTIONAL DOSE OMISSION 2 0.0001
272 PARALYSIS 1 0.0001
273 IMPAIRED QUALITY OF LIFE 1 0.0001
274 RASH 30 0.0001
275 SINUSITIS 7 0.0001
276 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
277 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
278 SKIN HAEMORRHAGE 1 0.0001
279 IMMUNODEFICIENCY 1 0.0001
280 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
281 RESPIRATORY DISORDER 2 0.0001
282 HYPOAESTHESIA ORAL 1 0.0001
283 THERAPEUTIC RESPONSE DECREASED 4 0.0001
284 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
285 SKIN IRRITATION 3 0.0001
286 OROPHARYNGEAL PAIN 6 0.0001
287 BASAL CELL CARCINOMA 1 0.0001
288 BRAIN FOG 1 0.0001
289 PNEUMOTHORAX 1 0.0001
290 ULCER 1 0.0001
291 CYSTITIS 2 0.0001
292 SCIATICA 1 0.0001
293 DEEP VEIN THROMBOSIS 4 0.0001
294 BACK DISORDER 1 0.0001
295 PHOTOSENSITIVITY REACTION 1 0.0001
296 SKIN DISORDER 2 0.0001
297 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
298 SCAR 1 0.0001
299 ERYTHEMA 12 0.0001
300 MUSCULOSKELETAL DISCOMFORT 1 0.0001
301 DEVICE USE ISSUE 1 0.0001
302 INJURY 4 0.0001
303 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
304 GALLBLADDER DISORDER 1 0.0001
305 CRYING 2 0.0001
306 HYPERGLYCAEMIA 2 0.0001
307 ARTHROPATHY 3 0.0001
308 MIDDLE INSOMNIA 1 0.0001
309 PHOTOPHOBIA 1 0.0001
310 BLOOD SODIUM DECREASED 1 0.0001
311 FRACTURE 1 0.0001
312 FEELING JITTERY 1 0.0001
313 SLEEP APNOEA SYNDROME 1 0.0001
314 ACUTE RESPIRATORY FAILURE 1 0.0001
315 ERUCTATION 1 0.0001
316 HAEMORRHOIDS 1 0.0001
317 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
318 CATARACT 3 0.0001
319 UPPER LIMB FRACTURE 1 0.0001
320 PRESCRIBED UNDERDOSE 1 0.0001
321 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
322 SPINAL FRACTURE 1 0.0000
323 TASTE DISORDER 1 0.0000
324 RIB FRACTURE 1 0.0000
325 MOUTH ULCERATION 1 0.0000
326 JOINT INJURY 1 0.0000
327 POOR QUALITY SLEEP 1 0.0000
328 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
329 FAECES DISCOLOURED 1 0.0000
330 SWELLING FACE 3 0.0000
331 PRODUCT DOSE OMISSION 3 0.0000
332 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
333 APPLICATION SITE PAIN 1 0.0000
334 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
335 LIVER DISORDER 2 0.0000
336 TRANSAMINASES INCREASED 1 0.0000
337 TOOTH DISORDER 1 0.0000
338 PRODUCT DOSE OMISSION ISSUE 13 0.0000
339 APPLICATION SITE PRURITUS 1 0.0000
340 PRODUCT AVAILABILITY ISSUE 1 0.0000
341 NEPHROLITHIASIS 2 0.0000
342 NASOPHARYNGITIS 8 0.0000
343 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
344 RENAL DISORDER 2 0.0000
345 BLOOD CHOLESTEROL INCREASED 2 0.0000
346 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
347 CHILLS 5 0.0000
348 SLEEP DISORDER 3 0.0000
349 MIGRAINE 4 0.0000
350 PRODUCTIVE COUGH 2 0.0000
351 RASH ERYTHEMATOUS 2 0.0000
352 LOCALISED INFECTION 1 0.0000
353 HYPOGLYCAEMIA 2 0.0000
354 FIBROMYALGIA 1 0.0000
355 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
356 AGEUSIA 1 0.0000
357 HALLUCINATION 3 0.0000
358 HAEMATEMESIS 1 0.0000
359 HYPOPHAGIA 1 0.0000
360 HAEMOGLOBIN DECREASED 4 0.0000
361 ERECTILE DYSFUNCTION 1 0.0000
362 DRUG RESISTANCE 1 0.0000
363 SKIN ULCER 1 0.0000
364 RASH GENERALISED 1 0.0000
365 EXPOSURE VIA SKIN CONTACT 1 0.0000
366 RESPIRATORY TRACT INFECTION 1 0.0000
367 GASTRITIS 1 0.0000
368 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
369 CARDIAC FAILURE 3 0.0000
370 OEDEMA 2 0.0000
371 FEELING COLD 1 0.0000
372 URTICARIA 6 0.0000
373 NECK PAIN 2 0.0000
374 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
375 FLATULENCE 2 0.0000
376 HERPES ZOSTER 2 0.0000
377 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
378 LIVER FUNCTION TEST ABNORMAL 1 0.0000
379 DYSSTASIA 1 0.0000
380 DYSPHONIA 2 0.0000
381 ACUTE MYOCARDIAL INFARCTION 1 0.0000
382 BLOOD POTASSIUM DECREASED 1 0.0000
383 NO ADVERSE EVENT 6 0.0000
384 PLEURAL EFFUSION 2 0.0000
385 VERTIGO 2 0.0000
386 DISCOMFORT 2 0.0000
387 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
388 FEMUR FRACTURE 1 0.0000
389 EXPOSURE DURING PREGNANCY 2 0.0000
390 PULMONARY EMBOLISM 3 0.0000
391 RHINORRHOEA 2 0.0000
392 PAIN IN EXTREMITY 9 0.0000
393 IMPAIRED HEALING 1 0.0000
394 INFUSION RELATED REACTION 2 0.0000
395 ABDOMINAL PAIN 7 0.0000
396 VIRAL INFECTION 1 0.0000
397 INSOMNIA 8 0.0000
398 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
399 HEPATIC ENZYME INCREASED 2 0.0000
400 URINARY TRACT INFECTION 5 0.0000
401 GASTRIC DISORDER 1 0.0000
402 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
403 LYMPHADENOPATHY 1 0.0000
404 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
405 SKIN BURNING SENSATION 2 0.0000
406 DIARRHOEA 18 0.0000
407 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
408 DRUG EFFECT INCOMPLETE 1 0.0000
409 C-REACTIVE PROTEIN INCREASED 1 0.0000
410 MUSCLE SPASMS 5 0.0000
411 DYSGEUSIA 2 0.0000
412 EPISTAXIS 2 0.0000
413 DYSPNOEA EXERTIONAL 1 0.0000
414 ASTHMA 3 0.0000
415 COLITIS 1 0.0000
416 INJECTION SITE SWELLING 2 0.0000
417 ALOPECIA 5 0.0000
418 ARTHRITIS 2 0.0000
419 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
420 ABORTION SPONTANEOUS 1 0.0000
421 JOINT SWELLING 3 0.0000
422 EXTRA DOSE ADMINISTERED 1 0.0000
423 DRY MOUTH 2 0.0000
424 CARDIAC ARREST 2 0.0000
425 FALL 8 0.0000
426 BALANCE DISORDER 2 0.0000
427 PYREXIA 8 0.0000
428 CONDITION AGGRAVATED 7 0.0000
429 DEVICE DISLOCATION 1 0.0000
430 SEPTIC SHOCK 1 0.0000
431 PSORIASIS 3 0.0000
432 CONSTIPATION 5 0.0000
433 INJECTION SITE PAIN 7 0.0000
434 COVID-19 4 0.0000
435 DEHYDRATION 3 0.0000
436 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
437 THROAT IRRITATION 1 0.0000
438 NEUTROPENIA 3 0.0000
439 VISION BLURRED 3 0.0000
440 SKIN DISCOLOURATION 1 0.0000
441 HYPOKALAEMIA 1 0.0000
442 DECREASED APPETITE 5 0.0000
443 WEIGHT DECREASED 6 0.0000
444 COUGH 6 0.0000
445 SWELLING 2 0.0000
446 PRODUCT USE ISSUE 4 0.0000
447 DYSPHAGIA 2 0.0000
448 COLORECTAL CANCER 1 0.0000
449 GAIT DISTURBANCE 4 0.0000
450 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
451 DRUG INTOLERANCE 2 0.0000
452 DYSPEPSIA 2 0.0000
453 NAUSEA 16 0.0000
454 DIZZINESS 10 0.0000
455 HYPOAESTHESIA 3 0.0000
456 AGGRESSION 1 0.0000
457 CHEST DISCOMFORT 2 0.0000
458 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
459 PERIPHERAL SWELLING 3 0.0000
460 ILLNESS 2 0.0000
461 INFLAMMATION 1 0.0000
462 MUSCULOSKELETAL PAIN 1 0.0000
463 SPEECH DISORDER 1 0.0000
464 DRUG INEFFECTIVE 25 0.0000
465 PANCREATITIS 1 0.0000
466 PLATELET COUNT DECREASED 2 0.0000
467 PNEUMONIA 6 0.0000
468 RASH PRURITIC 1 0.0000
469 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
470 HAEMATOCHEZIA 1 0.0000
471 INFLUENZA 2 0.0000
472 PANCYTOPENIA 1 0.0000
473 ABDOMINAL DISCOMFORT 3 0.0000
474 BLISTER 1 0.0000
475 MYALGIA 3 0.0000
476 PRODUCT SUBSTITUTION ISSUE 1 0.0000
477 BONE PAIN 1 0.0000
478 VOMITING 8 0.0000
479 DISEASE PROGRESSION 2 0.0000
480 WHEEZING 1 0.0000
481 FATIGUE 13 0.0000
482 IRRITABILITY 1 0.0000
483 SUICIDE ATTEMPT 1 0.0000
484 ILL-DEFINED DISORDER 1 0.0000
485 OEDEMA PERIPHERAL 2 0.0000
486 FEELING HOT 1 0.0000
487 PAIN 10 0.0000
488 HYPERSENSITIVITY 3 0.0000
489 ANAEMIA 3 0.0000
490 LOSS OF CONSCIOUSNESS 2 0.0000
491 BLOOD CREATININE INCREASED 1 0.0000
492 RENAL FAILURE 2 0.0000
493 HYPOTENSION 3 0.0000
494 INJECTION SITE PRURITUS 1 0.0000
495 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
496 MEMORY IMPAIRMENT 2 0.0000
497 ARTHRALGIA 6 0.0000
498 HEADACHE 9 0.0000
499 BURNING SENSATION 1 0.0000
500 THERAPY INTERRUPTED 1 0.0000
501 INFECTION 2 0.0000
502 RESPIRATORY FAILURE 1 0.0000
503 BRONCHITIS 1 0.0000
504 ASTHENIA 5 0.0000
505 UNEVALUABLE EVENT 1 0.0000
506 ACNE 1 0.0000
507 BACK PAIN 3 0.0000
508 OFF LABEL USE 11 0.0000
509 INJECTION SITE BRUISING 1 0.0000
510 DRUG DEPENDENCE 2 0.0000
511 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
512 INTENTIONAL PRODUCT MISUSE 1 0.0000
513 MUSCULOSKELETAL STIFFNESS 1 0.0000
514 MALAISE 5 0.0000
515 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
516 GASTROINTESTINAL DISORDER 1 0.0000
517 DEVICE ISSUE 1 0.0000
518 SUICIDAL IDEATION 1 0.0000
519 CHEST PAIN 2 0.0000
520 BREAST CANCER 1 0.0000
521 ANXIETY 3 0.0000
522 CONTUSION 1 0.0000
523 SYNCOPE 1 0.0000
524 FLUSHING 1 0.0000
525 ABDOMINAL PAIN UPPER 2 0.0000
526 ABDOMINAL DISTENSION 1 0.0000
527 WEIGHT INCREASED 2 0.0000
528 DYSPNOEA 5 0.0000
529 RHEUMATOID ARTHRITIS 1 0.0000
530 DEPRESSION 2 0.0000
531 FEELING ABNORMAL 2 0.0000
532 VISUAL IMPAIRMENT 1 0.0000
533 INJECTION SITE ERYTHEMA 1 0.0000
534 HYPERHIDROSIS 1 0.0000
535 PRODUCT QUALITY ISSUE 1 0.0000
536 DEATH 6 0.0000
537 BLOOD PRESSURE INCREASED 1 0.0000
538 CONFUSIONAL STATE 1 0.0000
539 DRUG DOSE OMISSION 1 0.0000
540 TREMOR 1 0.0000
541 SOMNOLENCE 1 0.0000
542 HYPERTENSION 1 0.0000
543 OVERDOSE 1 0.0000
544 INCORRECT DOSE ADMINISTERED 1 0.0000